ACADIA PHARMACEUTICALS INC

By person

22 insiders · 274 transactions

0.4×

Catherine Owen holds only 0.4 times base salary in stock. $434.28K of shares against $930.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Catherine Owen last reported holding, valued at $29.34, the price Common Stock was last bought or sold at on the open market here, on 6 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BAKER BROS. ADVISORS LP entity

Director

$341.51M (50)

—

+$341.51M

39,487,463

22.92%

$1.16B

+79.2%

DAVIS STEPHEN

CEO

—

$33.20M (38) scheduled

−$33.20M

186,555

0.1083%

$5.47M

+2,634%

Stankovic Srdjan R.

President

—

$19.28M (23) scheduled

−$19.28M

61,234

0.0355%

$1.80M

—

Baity Glenn

EVP AND GC

—

$10.63M (12) scheduled

−$10.63M

83,734

0.0486%

$2.46M

+32.1%

YANG MICHAEL J.

EVP and CCO

—

$7.18M (10) scheduled

−$7.18M

8,059

0.0047%

$236.43K

+820.0%

Moore Terrence O

EVP, CHIEF COMMERCIAL OFFICER

—

$6.58M (4) scheduled

−$6.58M

1,671

0.0010%

$49.02K

−54.0%

Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

—

$3.38M (31) scheduled

−$3.38M

67,828

0.0394%

$1.99M

+643.6%

Daly James M

Director

—

$3.15M (4) scheduled

−$3.15M

12,148

0.0071%

$356.39K

—

Ridloff Elena

EVP and CFO

—

$2.53M (8) scheduled

−$2.53M

10,553

0.0061%

$309.60K

—

Brege Laura

Director

—

$2.03M (6) scheduled

−$2.03M

23,202

0.0135%

$680.69K

—

KIM AUSTIN D.

EVP,General Counsel, Secretary

—

$1.90M (15) scheduled

−$1.90M

46,901

0.0272%

$1.38M

+866.8%

Miller Eric Alejandro

Controller & PAO

—

$1.32M (3) scheduled

−$1.32M

270

0.0002%

$7.92K

−94.2%

Kihara James

PRINCIPAL ACCOUNTING OFFICER

—

$1.29M (29) scheduled

−$1.29M

13,088

0.0076%

$383.97K

+63.5%

Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

—

$1.10M (16)

−$1.10M

62,105

0.0360%

$1.82M

+1,518%

Thompson Elizabeth H.Z.

EVP, Head of Research & Dev

—

$506.41K (3)

−$506.41K

18,994

0.0110%

$557.24K

—

Owen Adams Catherine

Chief Executive Officer

—

$249.93K (1)

−$249.93K

14,803

0.0086%

$434.28K

+404.4%

Rhodes Jennifer J

EVP, CHIEF LEGAL OFFICER, SEC

—

$245.02K (2)

−$245.02K

11,280

0.0065%

$330.93K

+598.5%

SOLAND DANIEL B

Director

$234.91K (4)

—

+$234.91K

44,041

0.0256%

$1.29M

—

GAROFALO ELIZABETH A.

Director

—

$131.23K (2)

−$131.23K

33,489

0.0194%

$982.48K

—

HARRIGAN EDMUND

Director

—

43,148

0.0250%

$1.27M

+4,215%

Ndu Adora

Director

—

32,908

0.0191%

$965.44K

—

Poole Jonathan

Director

—

2,010

0.0012%

$58.97K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Kihara James

26 Jun 2026

PRINCIPAL ACCOUNTING OFFICER

Sold on a plan

11,421

$26.08

$297.91K

Schneyer Mark C.

18 Aug 2025

EVP, CHIEF FINANCIAL OFFICER

Sold on a plan

22,000

$25.18

$554.02K

Schneyer Mark C.

16 May 2025

EVP, CHIEF FINANCIAL OFFICER

Sold on a plan

2,000

$25.00

$50.00K

Kihara James

16 May 2025

PRINCIPAL ACCOUNTING OFFICER

Sold on a plan

2,000

$20.00

$40.00K

Kihara James

16 May 2025

PRINCIPAL ACCOUNTING OFFICER

Sold on a plan

2,000

$25.00

$50.00K

Kihara James

15 Dec 2023

Principal Accounting Officer

Sold on a plan

2,000

$28.30

$56.60K

Kihara James

15 Sep 2023

Principal Accounting Officer

Sold on a plan

2,000

$25.88

$51.76K

Schneyer Mark C.

21 Aug 2023

EVP, Chief Financial Officer

Sold on a plan

10,000

$29.00

$289.97K

DAVIS STEPHEN

12 Jul 2023

CEO

Sold on a plan

55,104

$25.05

$1.38M

DAVIS STEPHEN

11 Jul 2023

CEO

Sold on a plan

16,498

$25.00

$412.45K

Kihara James

15 Jun 2023

Principal Accounting Officer

Sold on a plan

2,000

$24.15

$48.30K

Brege Laura

12 Jun 2023

Director

Sold on a plan

4,500

$24.87

$111.91K

Showing 250 of 274 transactions. The figures above use every one of them.

ACADIA PHARMACEUTICALS INC

By person

Individual transactions

What was left out